These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13597288)

  • 21. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of cardiotonic glycosides on blood coagulation and heparin sensitivity].
    CALTABIANO S; CAVALLINI L; CAGIANELLI MA
    G Clin Med; 1958 Sep; 39(9):1377-95. PubMed ID: 13610006
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers.
    Frank RD; Altenwerth B; Brandenburg VM; Nolden-Koch M; Block F
    Thromb Haemost; 2005 Aug; 94(2):467-8. PubMed ID: 16116692
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antagonistic effects of heparin during the second phase of coagulation].
    BURSTEIN M
    Sem Hop; 1954 Aug 26-30; 30(52-53):3051-4. PubMed ID: 13195759
    [No Abstract]   [Full Text] [Related]  

  • 25. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticoagulation and sepsis: the opportunity for a new use of heparin?].
    Jaimes F; de la Rosa G
    Biomedica; 2006 Mar; 26(1):150-60. PubMed ID: 16929913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of line flush heparin contamination on thromboelastograph trace analysis.
    Schulte A; Clark M
    Anaesthesia; 2008 Dec; 63(12):1381-2. PubMed ID: 19032319
    [No Abstract]   [Full Text] [Related]  

  • 28. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation.
    Pulitanò C; Aldrighetti L; Arru M; Finazzi R; Catena M; Guzzetti E; Soldini L; Comotti L; Ferla G
    Shock; 2007 Oct; 28(4):401-5. PubMed ID: 17577134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study.
    Drouet L; Bal dit Sollier C; Martin J
    Am Heart J; 2009 Aug; 158(2):177-84. PubMed ID: 19619692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation.
    Johnell M; Larsson R; Siegbahn A
    Biomaterials; 2005 May; 26(14):1731-9. PubMed ID: 15576147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The alleged intervention of lysozyme in processes of blood coagulation: research on rabbits & dogs].
    BRUCCHIERI A
    Boll Soc Ital Biol Sper; 1958 Nov; 34(22):1593-6. PubMed ID: 13607873
    [No Abstract]   [Full Text] [Related]  

  • 35. To use or not to use: the dilemma of NSAIDs and craniotomy.
    Umamaheswara Rao GS; Gelb AW
    Eur J Anaesthesiol; 2009 Aug; 26(8):625-6. PubMed ID: 19584610
    [No Abstract]   [Full Text] [Related]  

  • 36. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald D
    Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151
    [No Abstract]   [Full Text] [Related]  

  • 37. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Action of long-acting heparin preparation].
    MAZZETTI GM; CANDURA M
    Prog Med (Napoli); 1958 Jun; 14(11):336-40. PubMed ID: 13579029
    [No Abstract]   [Full Text] [Related]  

  • 39. [Curves of heparin action in operated children].
    CHABINKA W; HENNER I; TAKUSKA W
    Przegl Lek; 1954 Dec; 10(12a):404-7. PubMed ID: 14371832
    [No Abstract]   [Full Text] [Related]  

  • 40. [Curves of heparin action in patients operated on].
    CHABINKA W; TAKUSKA W; HENNER I
    Przegl Lek; 1954 Dec; 10(12a):401-4. PubMed ID: 14371831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.